Home › Companies › SPRINGWORKS THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and SPRINGWORKS THERAPEUTICS INC.’s Form 8-K, filed 2024-05-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Proxy season: 2023-2024 2024-2025
Explore SPRINGWORKS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are SPRINGWORKS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Freda Lewis-Hall | 50,328,375 | -- | 3,372,116 | 15,800,834 | 3,372,116 | Majority: yes |
| Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year endi | 69,485,322 | 5,709 | 10,294 | -- | -- | Majority: yes |
| Proposal 3 - Non-Binding Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the a | 38,332,463 | 27,761,536 | 3,407,326 | -- | 3,407,326 | Majority: yes |
Source: SPRINGWORKS THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-05-17 — read the filing on EDGAR.
Each item below shows how the 216 asset managers that disclosed a SPRINGWORKS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Proposal 3 - Non-Binding Advisory Vote on Executive Compensation The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy”): 38,332,463 for, 27,761,536 against, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 214 asset managers below cast 46.3% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 17,491,927 | 1,595,114 | 0 | 0 | For |
| New York Life | 0 | 9,095,819 | 0 | 0 | Against |
| Vanguard | 6,522,761 | 658,263 | 0 | 0 | For |
| T. Rowe Price | 0 | 7,157,859 | 0 | 0 | Against |
| BlackRock | 27,025 | 3,622,946 | 0 | 0 | Against |
| State Street | 2,896,660 | 18,626 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 2,159,858 | 0 | 0 | 0 | For |
| Lord Abbett | 1,985,256 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 0 | 1,975,620 | 0 | 0 | Against |
| ORBIMED ADVISORS LLC | 1,707,331 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 0 | 1,681,318 | 0 | 0 | Against |
| BNP Paribas Asset Management Holding S.A. | 0 | 1,509,922 | 0 | 0 | Against |
| Deep Track Capital, LP | 1,501,736 | 0 | 0 | 0 | For |
| Point72 | 0 | 1,501,114 | 0 | 0 | Against |
| MAVERICK CAPITAL LTD | 1,462,931 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 1,445,000 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 1,368,474 | 0 | 0 | Against |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,283,176 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,035,378 | 0 | 0 | Against |
| Voya | 0 | 986,795 | 0 | 0 | Against |
| Victory Capital | 0 | 985,526 | 0 | 0 | Against |
| Woodline Partners LP | 863,868 | 0 | 0 | 0 | For |
| Fiera Capital Corp | 0 | 824,202 | 0 | 0 | Against |
| Invesco | 0 | 817,425 | 0 | 0 | Against |
| Finepoint Capital LP | 0 | 592,528 | 0 | 0 | Against |
Showing the 25 largest of 214 asset managers. See all 214 in the interactive database.
Combines 2 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Freda Lewis-Hall”): 50,328,375 for, 15,800,834 withheld, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 67 asset managers below cast 100% of the shares they voted on this item FOR (24,531,849 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 8,017,780 | 0 | 1,400 | 0 | For |
| Vanguard | 7,000,544 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,187,978 | 0 | 0 | 0 | For |
| BlackRock | 2,048,193 | 0 | 0 | 0 | For |
| Lord Abbett | 1,985,256 | 0 | 0 | 0 | For |
| State Street | 820 | 0 | 822,806 | 0 | Abstain |
| Charles Schwab | 517,689 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 458,491 | 0 | Abstain |
| Voya | 0 | 0 | 452,700 | 0 | Abstain |
| Columbia Threadneedle | 434,872 | 0 | 0 | 0 | For |
| MFS | 0 | 0 | 398,622 | 0 | Abstain |
| Invesco | 0 | 0 | 373,777 | 0 | Abstain |
| Victory Capital | 0 | 0 | 361,448 | 0 | Abstain |
| MERIDIAN FUND INC | 328,832 | 0 | 0 | 0 | For |
| Equitable | 123,624 | 0 | 68,130 | 0 | For |
| TIAA | 174,579 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 12,501 | 0 | 123,725 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 118,476 | 0 | 0 | 0 | For |
| John Hancock | 53,531 | 0 | 45,639 | 0 | For |
| New York Life | 83,372 | 0 | 12,447 | 0 | For |
| Russell Investments | 88,240 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 81,412 | 0 | Abstain |
| MoA Funds Corp | 0 | 0 | 81,047 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 79,720 | 0 | Abstain |
| Jackson National | 0 | 0 | 72,517 | 0 | Abstain |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
SPRINGWORKS THERAPEUTICS INC.’s own tally for this item (“Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for ”): 69,485,322 for, 5,709 against, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
The 67 asset managers below cast 99.9% of the shares they voted on this item FOR (28,363,729 for, 167 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 8,019,180 | 0 | 0 | 0 | For |
| Vanguard | 7,000,544 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,187,978 | 0 | 0 | 0 | For |
| BlackRock | 2,048,193 | 0 | 0 | 0 | For |
| Lord Abbett | 1,985,256 | 0 | 0 | 0 | For |
| State Street | 823,626 | 0 | 0 | 0 | For |
| Charles Schwab | 517,689 | 0 | 0 | 0 | For |
| Dimensional | 458,491 | 0 | 0 | 0 | For |
| Voya | 452,700 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 434,872 | 0 | 0 | 0 | For |
| MFS | 398,622 | 0 | 0 | 0 | For |
| Invesco | 373,777 | 0 | 0 | 0 | For |
| Victory Capital | 361,448 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 328,832 | 0 | 0 | 0 | For |
| Equitable | 191,754 | 0 | 0 | 0 | For |
| TIAA | 174,579 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 136,226 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 118,476 | 0 | 0 | 0 | For |
| John Hancock | 99,170 | 0 | 0 | 0 | For |
| New York Life | 95,819 | 0 | 0 | 0 | For |
| Russell Investments | 88,240 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 81,412 | 0 | 0 | 0 | For |
| MoA Funds Corp | 81,047 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 79,720 | 0 | 0 | 0 | For |
| Jackson National | 72,517 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Ranked by the number of SPRINGWORKS THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Fidelity | 19,087,041 |
| 2 | New York Life | 9,095,819 |
| 3 | Vanguard | 7,181,024 |
| 4 | T. Rowe Price | 7,157,859 |
| 5 | BlackRock | 3,649,971 |
| 6 | State Street | 2,915,286 |
| 7 | LORD, ABBETT & CO. LLC | 2,159,858 |
| 8 | Lord Abbett | 1,985,256 |
| 9 | MARSHALL WACE, LLP | 1,975,620 |
| 10 | ORBIMED ADVISORS LLC | 1,707,331 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to SPRINGWORKS THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At SPRINGWORKS THERAPEUTICS INC.'s shareholder meeting held 2024-05-16, in the 2023-2024 proxy season, 216 asset managers reported how they voted on 3 ballot items in their SEC Form N-PX filings, covering 1,034 separate fund positions. On the most widely held item on that ballot — Non-binding advisory vote on executive compensation — FOR was 58% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SPRINGWORKS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-17.
SPRINGWORKS THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.